Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04953689 · ClinicalTrials.gov registry record · NA
Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04953689: Completed NA study, sponsored by State University of New York at Buffalo.
NCT04953689 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04953689, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a validation study of a conscientiousness-based phone app intervention strategy to help people with their health management and employment.
Primary Outcome
20 question self-report measure which assesses participants private self-consciousness using self-reflection and insight components. Total score of 20-120 points is calculated, with higher scores indicating greater self-reflection and insight.
Interventions
- BEHAVIORAL Conscientiousness Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2024-10-28 |
| Phase | NA |
What the finished NCT04953689 record still lists
NCT04953689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Conscientiousness Coach is the first listed.
NCT04953689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04953689 about?
NCT04953689 is a clinical study titled "Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis". This is a validation study of a conscientiousness-based phone app intervention strategy to help people with their health management and employment.
What is the current status of trial NCT04953689?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-10-19. Estimated completion is 2024-10-28.
What interventions are being tested in trial NCT04953689?
The interventions under investigation include: Conscientiousness Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT04953689?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04953689's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI